+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Drug Discovery Services Market by Service Type (Adme Dmpk Testing, Biomarker Discovery, Compound Synthesis & Scale Up), Technology (Computational Biology, Flow Cytometry, High Throughput Screening), Molecule Type, End User, Therapeutic Area - Global Forecast 2025-2030- Product Image
Drug Discovery Services Market by Service Type (Adme Dmpk Testing, Biomarker Discovery, Compound Synthesis & Scale Up), Technology (Computational Biology, Flow Cytometry, High Throughput Screening), Molecule Type, End User, Therapeutic Area - Global Forecast 2025-2030- Product Image
Sale

Drug Discovery Services Market by Service Type (Adme Dmpk Testing, Biomarker Discovery, Compound Synthesis & Scale Up), Technology (Computational Biology, Flow Cytometry, High Throughput Screening), Molecule Type, End User, Therapeutic Area - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 189 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 5146254
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The drug discovery services market is driving a new era of therapeutic innovation, enabling pharmaceutical and biotechnology companies to advance early-stage research more efficiently while leveraging specialized expertise and integrated solutions.

Market Snapshot: Growth & Momentum in Drug Discovery Services

The Drug Discovery Services Market grew from USD 24.79 billion in 2024 to USD 28.49 billion in 2025. It is expected to continue growing at a CAGR of 14.48%, reaching USD 55.84 billion by 2030. This sustained expansion is fueled by technological advancements, rising demand for outsourced R&D, and the evolving complexity of therapeutic pipelines. The focus on cost efficiency and accelerated timelines is compelling stakeholders to collaborate with contract research organizations offering end-to-end capabilities.

Scope & Segmentation: Comprehensive Coverage Across the Ecosystem

  • Service Types: ADME DMPK testing, biomarker discovery, compound synthesis and scale-up, hit screening, lead optimization, target identification, toxicity testing.
  • Technologies: Computational biology, flow cytometry, high throughput screening, mass spectrometry, nuclear magnetic resonance, X-ray crystallography.
  • Molecule Types: Biologics, oligonucleotides, peptides, small molecules.
  • End Users: Academic institutions, biotechnology companies, contract research organizations, pharmaceutical companies.
  • Therapeutic Areas: Cardiovascular disorders, central nervous system disorders, infectious diseases, metabolic disorders, oncology.
  • Geographic Regions: Americas (United States, Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (United Kingdom, Germany, France, Russia, Italy, Spain, United Arab Emirates, Saudi Arabia, South Africa, Denmark, Netherlands, Qatar, Finland, Sweden, Nigeria, Egypt, Turkey, Israel, Norway, Poland, Switzerland), and Asia-Pacific (China, India, Japan, Australia, South Korea, Indonesia, Thailand, Philippines, Malaysia, Singapore, Vietnam, Taiwan).
  • Company Developments: Charles River Laboratories International, Thermo Fisher Scientific, Labcorp, Evotec SE, IQVIA Holdings, Eurofins Scientific, Syngene International, Sai Life Sciences, TheraIndx Lifesciences, Drug Hunter, Vipragen Biosciences.

Key Takeaways: Strategic Insights for Senior Decision-Makers

  • Technological innovations, such as artificial intelligence and automation, continue to transform how drug discovery services are delivered, supporting faster compound identification and evaluation.
  • Integrated omics approaches enable a more holistic understanding of disease pathways, driving demand for advanced biomarker and phenotypic screening capabilities among service providers.
  • Demand from a wide spectrum of stakeholders—from major pharmaceutical corporations to biotech startups and academia—reflects the need for flexible service portfolios and deep domain expertise.
  • Geographical expansion offers strategic advantages; North America leads with established infrastructure, Europe invests in harmonized research platforms, and Asia-Pacific stands out for cost competitiveness and innovation scale.
  • Strategic alliances and digital infrastructure, such as cloud-based platforms, support operational transparency, collaboration, and efficient data management across global research projects.
  • Service providers differentiating on specialized expertise and innovative technology adoption are securing enduring partnerships with global sponsors.

Tariff Impact: Navigating Regulatory and Cost Challenges

New United States tariffs on imported reagents and research consumables are reshaping drug discovery service supply chains. Providers are adjusting procurement strategies, exploring alternative suppliers, and investing in process optimization to manage input cost fluctuations. This policy environment requires stakeholders to closely monitor ongoing changes and implement adaptive sourcing strategies that protect drug development timelines and operational resilience.

Methodology & Data Sources

Findings in this report draw on a combination of primary research, including interviews with industry leaders and subject matter experts, and secondary analysis of scientific publications, regulatory filings, and proprietary databases. Iterative validation and feedback from sector stakeholders ensure that insights reflect both market realities and future trends.

Why This Report Matters

  • Enables executives to benchmark current strategies against leading performers and emerging service models.
  • Identifies actionable opportunities in new technologies, underserved therapeutic areas, and geographic expansion.
  • Equips stakeholders with objective analysis to support R&D investment decisions and partnership development.

Conclusion

The drug discovery services market is evolving rapidly, shaped by technology, policy, and strategic collaboration. Organizations that integrate advanced solutions and agile models can capture emerging opportunities and maintain a competitive edge in this dynamic sector.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. AI-driven generative chemistry platforms enabling rapid de novo molecule design and optimization
5.2. Integration of CRISPR functional genomics screens with AI analytics for target validation scalability
5.3. High-throughput microfluidic organ-on-chip systems improving translational accuracy in toxicity profiling
5.4. Fragment-based lead discovery coupled with high-throughput cryo-electron microscopy for hit expansion
5.5. Single-cell multiomics data integration services accelerating personalized lead optimization strategies
5.6. Machine learning powered predictive ADMET modeling reducing late-stage drug development attrition rates
5.7. Quantum computing enhanced molecular docking services expediting complex structure-based lead selection workflows
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Drug Discovery Services Market, by Service Type
8.1. Introduction
8.2. Adme Dmpk Testing
8.2.1. Bioanalytical Services
8.2.2. In Vitro Adme
8.2.3. In Vivo Pharmacokinetics
8.3. Biomarker Discovery
8.3.1. Genomic Biomarkers
8.3.2. Metabolomic Biomarkers
8.3.3. Proteomic Biomarkers
8.4. Compound Synthesis & Scale Up
8.4.1. Custom Synthesis
8.4.2. Gmp Manufacturing
8.4.3. Process Development
8.5. Hit Screening
8.5.1. Fragment Screening
8.5.2. High Content Screening
8.5.3. High Throughput Screening
8.5.4. Virtual Screening
8.6. Lead Optimization
8.6.1. Admet Prediction
8.6.2. Computational Chemistry
8.6.3. Medicinal Chemistry
8.6.4. Structure Based Design
8.7. Target Identification
8.7.1. Bioinformatics
8.7.2. Genomics
8.7.3. High Content Screening
8.7.4. Proteomics
8.8. Toxicity Testing
8.8.1. In Vitro Toxicology
8.8.2. In Vivo Toxicology
8.8.3. Safety Pharmacology
9. Drug Discovery Services Market, by Technology
9.1. Introduction
9.2. Computational Biology
9.2.1. Bioinformatics
9.2.2. Cheminformatics
9.2.3. Molecular Modeling
9.3. Flow Cytometry
9.4. High Throughput Screening
9.4.1. Biochemical Assays
9.4.2. Cell Based Assays
9.4.3. Label Free Assays
9.5. Mass Spectrometry
9.6. Nuclear Magnetic Resonance
9.7. X Ray Crystallography
10. Drug Discovery Services Market, by Molecule Type
10.1. Introduction
10.2. Biologics
10.3. Oligonucleotides
10.4. Peptides
10.5. Small Molecules
11. Drug Discovery Services Market, by End User
11.1. Introduction
11.2. Academic Institutions
11.3. Biotechnology Companies
11.4. Contract Research Organizations
11.5. Pharmaceutical Companies
12. Drug Discovery Services Market, by Therapeutic Area
12.1. Introduction
12.2. Cardiovascular Disorders
12.3. Central Nervous System Disorders
12.4. Infectious Diseases
12.5. Metabolic Disorders
12.6. Oncology
13. Americas Drug Discovery Services Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Drug Discovery Services Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Drug Discovery Services Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Charles River Laboratories International, Inc.
16.3.2. Thermo Fisher Scientific Inc.
16.3.3. Labcorp.
16.3.4. Evotec SE
16.3.5. IQVIA Holdings Inc.
16.3.6. Eurofins Scientific SE
16.3.7. Syngene International Ltd.
16.3.8. Sai Life Sciences Limited
16.3.9. TheraIndx Lifesciences Pvt. Ltd.
16.3.10. Drug Hunter Inc.
16.3.11. Vipragen Biosciences Private Limited
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. DRUG DISCOVERY SERVICES MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY SERVICE TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY SERVICE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 8. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY MOLECULE TYPE, 2024 VS 2030 (%)
FIGURE 10. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY MOLECULE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2024 VS 2030 (%)
FIGURE 14. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS DRUG DISCOVERY SERVICES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS DRUG DISCOVERY SERVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES DRUG DISCOVERY SERVICES MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES DRUG DISCOVERY SERVICES MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA DRUG DISCOVERY SERVICES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA DRUG DISCOVERY SERVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC DRUG DISCOVERY SERVICES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC DRUG DISCOVERY SERVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. DRUG DISCOVERY SERVICES MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. DRUG DISCOVERY SERVICES MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 25. DRUG DISCOVERY SERVICES MARKET: RESEARCHAI
FIGURE 26. DRUG DISCOVERY SERVICES MARKET: RESEARCHSTATISTICS
FIGURE 27. DRUG DISCOVERY SERVICES MARKET: RESEARCHCONTACTS
FIGURE 28. DRUG DISCOVERY SERVICES MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. DRUG DISCOVERY SERVICES MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY SERVICE TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY ADME DMPK TESTING, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY ADME DMPK TESTING, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY BIOANALYTICAL SERVICES, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY BIOANALYTICAL SERVICES, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY IN VITRO ADME, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY IN VITRO ADME, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY IN VIVO PHARMACOKINETICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY IN VIVO PHARMACOKINETICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY ADME DMPK TESTING, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY ADME DMPK TESTING, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY BIOMARKER DISCOVERY, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY BIOMARKER DISCOVERY, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY GENOMIC BIOMARKERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY GENOMIC BIOMARKERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY METABOLOMIC BIOMARKERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY METABOLOMIC BIOMARKERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY PROTEOMIC BIOMARKERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY PROTEOMIC BIOMARKERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY BIOMARKER DISCOVERY, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY BIOMARKER DISCOVERY, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY COMPOUND SYNTHESIS & SCALE UP, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY COMPOUND SYNTHESIS & SCALE UP, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY CUSTOM SYNTHESIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY CUSTOM SYNTHESIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY GMP MANUFACTURING, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY GMP MANUFACTURING, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY PROCESS DEVELOPMENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY PROCESS DEVELOPMENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY COMPOUND SYNTHESIS & SCALE UP, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY COMPOUND SYNTHESIS & SCALE UP, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY HIT SCREENING, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY HIT SCREENING, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY FRAGMENT SCREENING, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY FRAGMENT SCREENING, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY HIGH CONTENT SCREENING, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY HIGH CONTENT SCREENING, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY HIGH THROUGHPUT SCREENING, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY HIGH THROUGHPUT SCREENING, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY VIRTUAL SCREENING, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY VIRTUAL SCREENING, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY HIT SCREENING, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY HIT SCREENING, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY LEAD OPTIMIZATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY LEAD OPTIMIZATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY ADMET PREDICTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY ADMET PREDICTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY COMPUTATIONAL CHEMISTRY, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY COMPUTATIONAL CHEMISTRY, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY MEDICINAL CHEMISTRY, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY MEDICINAL CHEMISTRY, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY STRUCTURE BASED DESIGN, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY STRUCTURE BASED DESIGN, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY LEAD OPTIMIZATION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY LEAD OPTIMIZATION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY TARGET IDENTIFICATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY TARGET IDENTIFICATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY BIOINFORMATICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY BIOINFORMATICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY GENOMICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY GENOMICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY HIGH CONTENT SCREENING, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY HIGH CONTENT SCREENING, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY PROTEOMICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY PROTEOMICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY TARGET IDENTIFICATION, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY TARGET IDENTIFICATION, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY TOXICITY TESTING, BY REGION, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY TOXICITY TESTING, BY REGION, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY IN VITRO TOXICOLOGY, BY REGION, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY IN VITRO TOXICOLOGY, BY REGION, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY IN VIVO TOXICOLOGY, BY REGION, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY IN VIVO TOXICOLOGY, BY REGION, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY SAFETY PHARMACOLOGY, BY REGION, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY SAFETY PHARMACOLOGY, BY REGION, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY TOXICITY TESTING, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY TOXICITY TESTING, 2025-2030 (USD MILLION)
TABLE 87. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 88. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 89. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY COMPUTATIONAL BIOLOGY, BY REGION, 2018-2024 (USD MILLION)
TABLE 90. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY COMPUTATIONAL BIOLOGY, BY REGION, 2025-2030 (USD MILLION)
TABLE 91. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY BIOINFORMATICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 92. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY BIOINFORMATICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 93. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY CHEMINFORMATICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 94. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY CHEMINFORMATICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 95. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY MOLECULAR MODELING, BY REGION, 2018-2024 (USD MILLION)
TABLE 96. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY MOLECULAR MODELING, BY REGION, 2025-2030 (USD MILLION)
TABLE 97. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY COMPUTATIONAL BIOLOGY, 2018-2024 (USD MILLION)
TABLE 98. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY COMPUTATIONAL BIOLOGY, 2025-2030 (USD MILLION)
TABLE 99. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY FLOW CYTOMETRY, BY REGION, 2018-2024 (USD MILLION)
TABLE 100. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY FLOW CYTOMETRY, BY REGION, 2025-2030 (USD MILLION)
TABLE 101. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY HIGH THROUGHPUT SCREENING, BY REGION, 2018-2024 (USD MILLION)
TABLE 102. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY HIGH THROUGHPUT SCREENING, BY REGION, 2025-2030 (USD MILLION)
TABLE 103. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY BIOCHEMICAL ASSAYS, BY REGION, 2018-2024 (USD MILLION)
TABLE 104. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY BIOCHEMICAL ASSAYS, BY REGION, 2025-2030 (USD MILLION)
TABLE 105. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY CELL BASED ASSAYS, BY REGION, 2018-2024 (USD MILLION)
TABLE 106. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY CELL BASED ASSAYS, BY REGION, 2025-2030 (USD MILLION)
TABLE 107. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY LABEL FREE ASSAYS, BY REGION, 2018-2024 (USD MILLION)
TABLE 108. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY LABEL FREE ASSAYS, BY REGION, 2025-2030 (USD MILLION)
TABLE 109. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY HIGH THROUGHPUT SCREENING, 2018-2024 (USD MILLION)
TABLE 110. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY HIGH THROUGHPUT SCREENING, 2025-2030 (USD MILLION)
TABLE 111. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY MASS SPECTROMETRY, BY REGION, 2018-2024 (USD MILLION)
TABLE 112. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY MASS SPECTROMETRY, BY REGION, 2025-2030 (USD MILLION)
TABLE 113. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY NUCLEAR MAGNETIC RESONANCE, BY REGION, 2018-2024 (USD MILLION)
TABLE 114. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY NUCLEAR MAGNETIC RESONANCE, BY REGION, 2025-2030 (USD MILLION)
TABLE 115. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY X RAY CRYSTALLOGRAPHY, BY REGION, 2018-2024 (USD MILLION)
TABLE 116. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY X RAY CRYSTALLOGRAPHY, BY REGION, 2025-2030 (USD MILLION)
TABLE 117. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY MOLECULE TYPE, 2018-2024 (USD MILLION)
TABLE 118. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY MOLECULE TYPE, 2025-2030 (USD MILLION)
TABLE 119. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY BIOLOGICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 120. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY BIOLOGICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 121. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY OLIGONUCLEOTIDES, BY REGION, 2018-2024 (USD MILLION)
TABLE 122. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY OLIGONUCLEOTIDES, BY REGION, 2025-2030 (USD MILLION)
TABLE 123. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY PEPTIDES, BY REGION, 2018-2024 (USD MILLION)
TABLE 124. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY PEPTIDES, BY REGION, 2025-2030 (USD MILLION)
TABLE 125. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY SMALL MOLECULES, BY REGION, 2018-2024 (USD MILLION)
TABLE 126. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY SMALL MOLECULES, BY REGION, 2025-2030 (USD MILLION)
TABLE 127. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 128. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 129. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY ACADEMIC INSTITUTIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 130. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY ACADEMIC INSTITUTIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 131. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 132. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 133. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 134. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 135. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 136. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 137. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 138. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 139. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY CARDIOVASCULAR DISORDERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 140. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY CARDIOVASCULAR DISORDERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 141. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY CENTRAL NERVOUS SYSTEM DISORDERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 142. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY CENTRAL NERVOUS SYSTEM DISORDERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 143. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2024 (USD MILLION)
TABLE 144. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2025-2030 (USD MILLION)
TABLE 145. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY METABOLIC DISORDERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 146. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY METABOLIC DISORDERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 147. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2024 (USD MILLION)
TABLE 148. GLOBAL DRUG DISCOVERY SERVICES MARKET SIZE, BY ONCOLOGY, BY REGION, 2025-2030 (USD MILLION)
TABLE 149. AMERICAS DRUG DISCOVERY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
TABLE 150. AMERICAS DRUG DISCOVERY SERVICES MARKET SIZE, BY SERVICE TYPE, 2025-2030 (USD MILLION)
TABLE 151. AMERICAS DRUG DISCOVERY SERVICES MARKET SIZE, BY ADME DMPK TESTING, 2018-2024 (USD MILLION)
TABLE 152. AMERICAS DRUG DISCOVERY SERVICES MARKET SIZE, BY ADME DMPK TESTING, 2025-2030 (USD MILLION)
TABLE 153. AMERICAS DRUG DISCOVERY SERVICES MARKET SIZE, BY BIOMARKER DISCOVERY, 2018-2024 (USD MILLION)
TABLE 154. AMERICAS DRUG DISCOVERY SERVICES MARKET SIZE, BY BIOMARKER DISCOVERY, 2025-2030 (USD MILLION)
TABLE 155. AMERICAS DRUG DISCOVERY SERVICES MARKET SIZE, BY COMPOUND SYNTHESIS & SCALE UP, 2018-2024 (USD MILLION)
TABLE 156. AMERICAS DRUG DISCOVERY SERVICES MARKET SIZE, BY COMPOUND SYNTHESIS & SCALE UP, 2025-2030 (USD MILLION)
TABLE 157. AMERICAS DRUG DISCOVERY SERVICES MARKET SIZE, BY HIT SCREENING, 2018-2024 (USD MILLION)
TABLE 158. AMERICAS DRUG DISCOVERY SERVICES MARKET SIZE, BY HIT SCREENING, 2025-2030 (USD MILLION)
TABLE 159. AMERICAS DRUG DISCOVERY SERVICES MARKET SIZE, BY LEAD OPTIMIZATION, 2018-2024 (USD MILLION)
TABLE 160. AMERICAS DRUG DISCOVERY SERVICES MARKET SIZE, BY LEAD OPTIMIZATION, 2025-2030 (USD MILLION)
TABLE 161. AMERICAS DRUG DISCOVERY SERVICES MARKET SIZE, BY TARGET IDENTIFICATION, 2018-2024 (USD MILLION)
TABLE 162. AMERICAS DRUG DISCOVERY SERVICES MARKET SIZE, BY TARGET IDENTIFICATION, 2025-2030 (USD MILLION)
TABLE 163. AMERICAS DRUG DISCOVERY SERVICES MARKET SIZE, BY TOXICITY TESTING, 2018-2024 (USD MILLION)
TABLE 164. AMERICAS DRUG DISCOVERY SERVICES MARKET SIZE, BY TOXICITY TESTING, 2025-2030 (USD MILLION)
TABLE 165. AMERICAS DRUG DISCOVERY SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 166. AMERICAS DRUG DISCOVERY SERVICES MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 167. AMERICAS DRUG DISCOVERY SERVICES MARKET SIZE, BY COMPUTATIONAL BIOLOGY, 2018-2024 (USD MILLION)
TABLE 168. AMERICAS DRUG DISCOVERY SERVICES MARKET SIZE, BY COMPUTATIONAL BIOLOGY, 2025-2030 (USD MILLION)
TABLE 169. AMERICAS DRUG DISCOVERY SERVICES MARKET SIZE, BY HIGH THROUGHPUT SCREENING, 2018-2024 (USD MILLION)
TABLE 170. AMERICAS DRUG DISCOVERY SERVICES MARKET SIZE, BY HIGH THROUGHPUT SCREENING, 2025-2030 (USD MILLION)
TABLE 171. AMERICAS DRUG DISCOVERY SERVICES MARKET SIZE, BY MOLECULE TYPE, 2018-2024 (USD MILLION)
TABLE 172. AMERICAS DRUG DISCOVERY SERVICES MARKET SIZE, BY MOLECULE TYPE, 2025-2030 (USD MILLION)
TABLE 173. AMERICAS DRUG DISCOVERY SERVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 174. AMERICAS DRUG DISCOVERY SERVICES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 175. AMERICAS DRUG DISCOVERY SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 176. AMERICAS DRUG DISCOVERY SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 177. AMERICAS DRUG DISCOVERY SERVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 178. AMERICAS DRUG DISCOVERY SERVICES MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 179. UNITED STATES DRUG DISCOVERY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
TABLE 180. UNITED STATES DRUG DISCOVERY SERVICES MARKET SIZE, BY SERVICE TYPE, 2025-2030 (USD MILLION)
TABLE 181. UNITED STATES DRUG DISCOVERY SERVICES MARKET SIZE, BY ADME DMPK TESTING, 2018-2024 (USD MILLION)
TABLE 182. UNITED STATES DRUG DISCOVERY SERVICES MARKET SIZE, BY ADME DMPK TESTING, 2025-2030 (USD MILLION)
TABLE 183. UNITED STATES DRUG DISCOVERY SERVICES MARKET SIZE, BY BIOMARKER DISCOVERY, 2018-2024 (USD MILLION)
TABLE 184. UNITED STATES DRUG DISCOVERY SERVICES MARKET SIZE, BY BIOMARKER DISCOVERY, 2025-2030 (USD MILLION)
TABLE 185. UNITED STATES DRUG DISCOVERY SERVICES MARKET SIZE, BY COMPOUND SYNTHESIS & SCALE UP, 2018-2024 (USD MILLION)
TABLE 186. UNITED STATES DRUG DISCOVERY SERVICES MARKET SIZE, BY COMPOUND SYNTHESIS & SCALE UP, 2025-2030 (USD MILLION)
TABLE 187. UNITED STATES DRUG DISCOVERY SERVICES MARKET SIZE, BY HIT SCREENING, 2018-2024 (USD MILLION)
TABLE 188. UNITED STATES DRUG DISCOVERY SERVICES MARKET SIZE, BY HIT SCREENING, 2025-2030 (USD MILLION)
TABLE 189. UNITED STATES DRUG DISCOVERY SERVICES MARKET SIZE, BY LEAD OPTIMIZATION, 2018-2024 (USD MILLION)
TABLE 190. UNITED STATES DRUG DISCOVERY SERVICES MARKET SIZE, BY LEAD OPTIMIZATION, 2025-2030 (USD MILLION)
TABLE 191. UNITED STATES DRUG DISCOVERY SERVICES MARKET SIZE, BY TARGET IDENTIFICATION, 2018-2024 (USD MILLION)
TABLE 192. UNITED STATES DRUG DISCOVERY SERVICES MARKET SIZE, BY TARGET IDENTIFICATION, 2025-2030 (USD MILLION)
TABLE 193. UNITED STATES DRUG DISCOVERY SERVICES MARKET SIZE, BY TOXICITY TESTING, 2018-2024 (USD MILLION)
TABLE 194. UNITED STATES DRUG DISCOVERY SERVICES MARKET SIZE, BY TOXICITY TESTING, 2025-2030 (USD MILLION)
TABLE 195. UNITED STATES DRUG DISCOVERY SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 196. UNITED STATES DRUG DISCOVERY SERVICES MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 197. UNITED STATES DRUG DISCOVERY SERVICES MARKET SIZE, BY COMPUTATIONAL BIOLOGY, 2018-2024 (USD MILLION)
TABLE 198. UNITED STATES DRUG DISCOVERY SERVICES MARKET SIZE, BY COMPUTATIONAL BIOLOGY, 2025-2030 (USD MILLION)
TABLE 199. UNITED STATES DRUG DISCOVERY SERVICES MARKET SIZE, BY HIGH THROUGHPUT SCREENING, 2018-2024 (USD MILLION)
TABLE 200. UNITED STATES DRUG DISCOVERY SERVICES MARKET SIZE, BY HIGH THROUGHPUT SCREENING, 2025-2030 (USD MILLION)
TABLE 201. UNITED STATES DRUG DISCOVERY SERVICES MARKET SIZE, BY MOLECULE TYPE, 2018-2024 (USD MILLION)
TABLE 202. UNITED STATES DRUG DISCOVERY SERVICES MARKET SIZE, BY MOLECULE TYPE, 2025-2030 (USD MILLION)
TABLE 203. UNITED STATES DRUG DISCOVERY SERVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 204. UNITED STATES DRUG DISCOVERY SERVICES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 205. UNITED STATES DRUG DISCOVERY SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 206. UNITED STATES DRUG DISCOVERY SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 207. UNITED STATES DRUG DISCOVERY SERVICES MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 208. UNITED STATES DRUG DISCOVERY SERVICES MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 209. CANADA DRUG DISCOVERY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
TABLE 210. CANADA DRUG DISCOVERY SERVICES MARKET SIZE, BY SERVICE TYPE, 2025-2030 (USD MILLION)
TABLE 211. CANADA DRUG DISCOVERY SERVICES MARKET SIZE, BY ADME DMPK TESTING, 2018-2024 (USD MILLION)
TABLE 212. CANADA DRUG DISCOVERY SERVICES MARKET SIZE, BY ADME DMPK TESTING, 2025-2030 (USD MILLION)
TABLE 213. CANADA DRUG DISCOVERY SERVICES MARKET SIZE, BY BIOMARKER DISCOVERY, 2018-2024 (USD MILLION)
TABLE 214. CANADA DRUG DISCOVERY SERVICES MARKET SIZE, BY BIOMARKER DISCOVERY, 2025-2030 (USD MILLION)
TABLE 215. CANADA DRUG DISCOVERY SERVICES MARKET SIZE, BY COMPOUND SYNTHESIS & SCALE UP, 2018-2024 (USD MILLION)
TABLE 216. CANADA DRUG DISCOVERY SERVICES MARKET SIZE, BY COMPOUND SYNTHESIS & SCALE UP, 2025-2030 (USD MILLION)
TABLE 217. CANADA DRUG DISCOVERY SERVICES MARKET SIZE, BY HIT SCREENING, 2018-2024 (USD MILLION)
TABLE 218. CANADA DRUG DISCOVERY SERVICES MARKET SIZE, BY HIT SCREENING, 2025-2030 (USD MILLION)
TABLE 219. CANADA DRUG DISCOVERY SERVICES MARKET SIZE, BY LEAD OPTIMIZATION, 2018-2024 (USD MILLION)
TABLE 220. CANADA DRUG DISCOVERY SERVICES MARKET SIZE, BY LEAD OPTIMIZATION, 2025-2030 (USD MILLION)
TABLE 221. CANADA DRUG DISCOVERY SERVICES MARKET SIZE, BY TARGET IDENTIFICATION, 2018-2024 (USD MILLION)
TABLE 222. CANADA DRUG DISCOVERY SERVICES MARKET SIZE, BY TARGET IDENTIFICATION, 2025-2030 (USD MILLION)
TABLE 223. CANADA DRUG DISCOVERY SERVICES MARKET SIZE, BY TOXICITY TESTING, 2018-2024 (USD MILLION)
TABLE 224. CANADA DRUG DISCOVERY SERVICES MARKET SIZE, BY TOXICITY TESTING, 2025-2030 (USD MILLION)
TABLE 225. CANADA DRUG DISCOVERY SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 226. CANADA DRUG DISCOVERY SERVICES MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 227. CANADA DRUG DISCOVERY SERVICES MARKET SIZE, BY COMPUTATIONAL BIOLOGY, 2018-2024 (USD MILLION)
TABLE 228. CANADA DRUG DISCOVERY SERVICES MARKET SIZE, BY COMPUTATIONAL BIOLOGY, 2025-2030 (USD MILLION)
TABLE 229. CANADA DRUG DISCOVERY SERVICES MARKET SIZE, BY HIGH THROUGHPUT SCREENING, 2018-2024 (USD MILLION)
TABLE 230. CANADA DRUG DISCOVERY SERVICES MARKET SIZE, BY HIGH THROUGHPUT SCREENING, 2025-2030 (USD MILLION)
TABLE 231. CANADA DRUG DISCOVERY SERVICES MARKET SIZE, BY MOLECULE TYPE, 2018-2024 (USD MILLION)
TABLE 232. CANADA DRUG DISCOVERY SERVICES MARKET SIZE, BY MOLECULE TYPE, 2025-2030 (USD MILLION)
TABLE 233. CANADA DRUG DISCOVERY SERVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 234. CANADA DRUG DISCOVERY SERVICES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 235. CANADA DRUG DISCOVERY SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 236. CANADA DRUG DISCOVERY SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 237. MEXICO DRUG DISCOVERY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
TABLE 238. MEXICO DRUG DISCOVERY SERVICES MARKET SIZE, BY SERVICE TYPE, 2025-2030 (USD MILLION)
TABLE 239. MEXICO DRUG DISCOVERY SERVICES MARKET SIZE, BY ADME DMPK TESTING, 2018-2024 (USD MILLION)
TABLE 240. MEXICO DRUG DISCOVERY SERVICES MARKET SIZE, BY ADME DMPK TESTING, 2025-2030 (USD MILLION)
TABLE 241. MEXICO DRUG DISCOVERY SERVICES MARKET SIZE, BY BIOMARKER DISCOVERY, 2018-2024 (USD MILLION)
TABLE 242. MEXICO DRUG DISCOVERY SERVICES MARKET SIZE, BY BIOMARKER DISCOVERY, 2025-2030 (USD MILLION)
TABLE 243. MEXICO DRUG DISCOVERY SERVICES MARKET SIZE, BY COMPOUND SYNTHESIS & SCALE UP, 2018-2024 (USD MILLION)
TABLE 244. MEXICO DRUG DISCOVERY SERVICES MARKET SIZE, BY COMPOUND SYNTHESIS & SCALE UP, 2025-2030 (USD MILLION)
TABLE 245. MEXICO DRUG DISCOVERY SERVICES MARKET SIZE, BY HIT SCREENING, 2018-2024 (USD MILLION)
TABLE 246. MEXICO DRUG DISCOVERY SERVICES MARKET SIZE, BY HIT SCREENING, 2025-2030 (USD MILLION)
TABLE 247. MEXICO DRUG DISCOVERY SERVICES MARKET SIZE, BY LEAD OPTIMIZATION, 2018-2024 (USD MILLION)
TABLE 248. MEXICO DRUG DISCOVERY SERVICES MARKET SIZE, BY LEAD OPTIMIZATION, 2025-2030 (USD MILLION)
TABLE 249. MEXICO DRUG DISCOVERY SERVICES MARKET SIZE, BY TARGET IDENTIFICATION, 2018-2024 (USD MILLION)
TABLE 250. MEXICO DRUG DISCOVERY SERVICES MARKET SIZE, BY TARGET IDENTIFICATION, 2025-2030 (USD MILLION)
TABLE 251. MEXICO DRUG DISCOVERY SERVICES MARKET SIZE, BY TOXICITY TESTING, 2018-2024 (USD MILLION)
TABLE 252. MEXICO DRUG DISCOVERY SERVICES MARKET SIZE, BY TOXICITY TESTING, 2025-2030 (USD MILLION)
TABLE 253. MEXICO DRUG DISCOVERY SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 254. MEXICO DRUG DISCOVERY SERVICES MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 255. MEXICO DRUG DISCOVERY SERVICES MARKET SIZE, BY COMPUTATIONAL BIOLOGY, 2018-2024 (USD MILLION)
TABLE 256. MEXICO DRUG DISCOVERY SERVICES MARKET SIZE, BY COMPUTATIONAL BIOLOGY, 2025-2030 (USD MILLION)
TABLE 257. MEXICO DRUG DISCOVERY SERVICES MARKET SIZE, BY HIGH THROUGHPUT SCREENING, 2018-2024 (USD MILLION)
TABLE 258. MEXICO DRUG DISCOVERY SERVICES MARKET SIZE, BY HIGH THROUGHPUT SCREENING, 2025-2030 (USD MILLION)
TABLE 259. MEXICO DRUG DISCOVERY SERVICES MARKET SIZE, BY MOLECULE TYPE, 2018-2024 (USD MILLION)
TABLE 260. MEXICO DRUG DISCOVERY SERVICES MARKET SIZE, BY MOLECULE TYPE, 2025-2030 (USD MILLION)
TABLE 261. MEXICO DRUG DISCOVERY SERVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 262. MEXICO DRUG DISCOVERY SERVICES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 263. MEXICO DRUG DISCOVERY SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 264. MEXICO DRUG DISCOVERY SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 265. BRAZIL DRUG DISCOVERY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
TABLE 266. BRAZIL DRUG DISCOVERY SERVICES MARKET SIZE, BY SERVICE TYPE, 2025-2030 (USD MILLION)
TABLE 267. BRAZIL DRUG DISCOVERY SERVICES MARKET SIZE, BY ADME DMPK TESTING, 2018-2024 (USD MILLION)
TABLE 268. BRAZIL DRUG DISCOVERY SERVICES MARKET SIZE, BY ADME DMPK TESTING, 2025-2030 (USD MILLION)
TABLE 269. BRAZIL DRUG DISCOVERY SERVICES MARKET SIZE, BY BIOMARKER DISCOVERY, 2018-2024 (USD MILLION)
TABLE 270. BRAZIL DRUG DISCOVERY SERVICES MARKET SIZE, BY BIOMARKER DISCOVERY, 2025-2030 (USD MILLION)
TABLE 271. BRAZIL DRUG DISCOVERY SERVICES MARKET SIZE, BY COMPOUND SYNTHESIS & SCALE UP, 2018-2024 (USD MILLION)
TABLE 272. BRAZIL DRUG DISCOVERY SERVICES MARKET SIZE, BY COMPOUND SYNTHESIS & SCALE UP, 2025-2030 (USD MILLION)
TABLE 273. BRAZIL DRUG DISCOVERY SERVICES MARKET SIZE, BY HIT SCREENING, 2018-2024 (USD MILLION)
TABLE 274. BRAZIL DRUG DISCOVERY SERVICES MARKET SIZE, BY HIT SCREENING, 2025-2030 (USD MILLION)
TABLE 275. BRAZIL DRUG DISCOVERY SERVICES MARKET SIZE, BY LEAD OPTIMIZATION, 2018-2024 (USD MILLION)
TABLE 276. BRAZIL DRUG DISCOVERY SERVICES MARKET SIZE, BY LEAD OPTIMIZATION, 2025-2030 (USD MILLION)
TABLE 277. BRAZIL DRUG DISCOVERY SERVICES MARKET SIZE, BY TARGET IDENTIFICATION, 2018-2024 (USD MILLION)
TABLE 278. BRAZIL DRUG DISCOVERY SERVICES MARKET SIZE, BY TARGET IDENTIFICATION, 2025-2030 (USD MILLION)
TABLE 279. BRAZIL DRUG DISCOVERY SERVICES MARKET SIZE, BY TOXICITY TESTING, 2018-2024 (USD MILLION)
TABLE 280. BRAZIL DRUG DISCOVERY SERVICES MARKET SIZE, BY TOXICITY TESTING, 2025-2030 (USD MILLION)
TABLE 281. BRAZIL DRUG DISCOVERY SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 282. BRAZIL DRUG DISCOVERY SERVICES MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 283. BRAZIL DRUG DISCOVERY SERVICES MARKET SIZE, BY COMPUTATIONAL BIOLOGY, 2018-2024 (USD MILLION)
TABLE 284. BRAZIL DRUG DISCOVERY SERVICES MARKET SIZE, BY COMPUTATIONAL BIOLOGY, 2025-2030 (USD MILLION)
TABLE 285. BRAZIL DRUG DISCOVERY SERVICES MARKET SIZE, BY HIGH THROUGHPUT SCREENING, 2018-2024 (USD MILLION)
TABLE 286. BRAZIL DRUG DISCOVERY SERVICES MARKET SIZE, BY HIGH THROUGHPUT SCREENING, 2025-2030 (USD MILLION)
TABLE 287. BRAZIL DRUG DISCOVERY SERVICES MARKET SIZE, BY MOLECULE TYPE, 2018-2024 (USD MILLION)
TABLE 288. BRAZIL DRUG DISCOVERY SERVICES MARKET SIZE, BY MOLECULE TYPE, 2025-2030 (USD MILLION)
TABLE 289. BRAZIL DRUG DISCOVERY SERVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 290. BRAZIL DRUG DISCOVERY SERVICES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 291. BRAZIL DRUG DISCOVERY SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 292. BRAZIL DRUG DISCOVERY SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 293. ARGENTINA DRUG DISCOVERY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
TABLE 294. ARGENTINA DRUG DISCOVERY SERVICES MARKET SIZE, BY SERVICE TYPE, 2025-2030 (USD MILLION)
TABLE 295. ARGENTINA DRUG DISCOVERY SERVICES MARKET SIZE, BY ADME DMPK TESTING, 2018-2024 (USD MILLION)
TABLE 296. ARGENTINA DRUG DISCOVERY SERVICES MARKET SIZE, BY ADME DMPK TESTING, 2025-2030 (USD MILLION)
TABLE 297. ARGENTINA DRUG DISCOVERY SERVICES MARKET SIZE, BY BIOMARKER DISCOVERY, 2018-2024 (USD MILLION)
TABLE 298. ARGENTINA DRUG DISCOVERY SERVICES MARKET SIZE, BY BIOMARKER DISCOVERY, 2025-2030 (USD MILLION)
TABLE 299. ARGENTINA DRUG DISCOVERY SERVICES MARKET SIZE, BY COMPOUND SYNTHESIS & SCALE UP, 2018-2024 (USD MILLION)
TABLE 300. ARGENTINA DRUG DISCOVERY SERVICES MARKET SIZE, BY COMPOUND SYNTHESIS & SCALE UP, 2025-2030 (USD MILLION)
TABLE 301. ARGENTINA DRUG DISCOVERY SERVICES MARKET SIZE, BY HIT SCREENING, 2018-2024 (USD MILLION)
TABLE 302. ARGENTINA DRUG DISCOVERY SERVICES MARKET SIZE, BY HIT SCREENING, 2025-2030 (USD MILLION)
TABLE 303. ARGENTINA DRUG DISCOVERY SERVICES MARKET SIZE, BY LEAD OPTIMIZATION, 2018-2024 (USD MILLION)
TABLE 304. ARGENTINA DRUG DISCOVERY SERVICES MARKET SIZE, BY LEAD OPTIMIZATION, 2025-2030 (USD MILLION)
TABLE 305. ARGENTINA DRUG DISCOVERY SERVICES MARKET SIZE, BY TARGET IDENTIFICATION, 2018-2024 (USD MILLION)
TABLE 306. ARGENTINA DRUG DISCOVERY SERVICES MARKET SIZE, BY TARGET IDENTIFICATION, 2025-2030 (USD MILLION)
TABLE 307. ARGENTINA DRUG DISCOVERY SERVICES MARKET SIZE, BY TOXICITY TESTING, 2018-2024 (USD MILLION)
TABLE 308. ARGENTINA DRUG DISCOVERY SERVICES MARKET SIZE, BY TOXICITY TESTING, 2025-2030 (USD MILLION)
TABLE 309. ARGENTINA DRUG DISCOVERY SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 310. ARGENTINA DRUG DISCOVERY SERVICES MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 311. ARGENTINA DRUG DISCOVERY

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Drug Discovery Services market report include:
  • Charles River Laboratories International, Inc.
  • Thermo Fisher Scientific Inc.
  • Labcorp.
  • Evotec SE
  • IQVIA Holdings Inc.
  • Eurofins Scientific SE
  • Syngene International Ltd.
  • Sai Life Sciences Limited
  • TheraIndx Lifesciences Pvt. Ltd.
  • Drug Hunter Inc.
  • Vipragen Biosciences Private Limited

Table Information

Report AttributeDetails
No. of Pages189
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 28.49 Billion
Forecasted Market Value ( USD ) by 2030 $ 55.84 Billion
Compound Annual Growth Rate14.4%
Regions CoveredGlobal
No. of Companies Mentioned12

Related Topics

Related Reports

In-Vitro Toxicology Testing Market by Service Type (Biochemical Assays, Cell Culture Assays, Computational Models), Technology (High Throughput Screening, Microfluidics, Organ On Chip), Application, End User - Global Forecast 2025-2030 - Product Image

In-Vitro Toxicology Testing Market by Service Type (Biochemical Assays, Cell Culture Assays, Computational Models), Technology (High Throughput Screening, Microfluidics, Organ On Chip), Application, End User - Global Forecast 2025-2030

  • Report
  • 191 Pages
  • Global
From
Drug Discovery Services - Company Evaluation Report, 2025 - Product Image

Drug Discovery Services - Company Evaluation Report, 2025

  • Report
  • 155 Pages
  • Global
From
Drug Discovery Services Market by Process (Target Validation, Hit-to-Lead, Lead Optimization), Type (Chemistry, Biology), Therapeutic Area (Oncology, Neurology, Infectious, CVD), Drug Type (Small Molecules, Biologics), End User - Global Forecast to 2030 - Product Image

Drug Discovery Services Market by Process (Target Validation, Hit-to-Lead, Lead Optimization), Type (Chemistry, Biology), Therapeutic Area (Oncology, Neurology, Infectious, CVD), Drug Type (Small Molecules, Biologics), End User - Global Forecast to 2030

  • Report
  • 451 Pages
  • Global
From
Drug Discovery Services - Global Strategic Business Report - Product Image

Drug Discovery Services - Global Strategic Business Report

  • Report
  • 372 Pages
  • Global
From
Drug Discovery Services Market Report 2025 - Product Image

Drug Discovery Services Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.